An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development

Cannabidiol (CBD), a major non-psychoactive component of the cannabis plant, has shown therapeutic potential in Alzheimer’s disease (AD). In this study, we identified potential CBD targets associated with AD using a drug-target binding affinity prediction model and generated CBD analogs using a gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Kyudam, Lee, Yurim, Kim, Cheongwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648567/
https://www.ncbi.nlm.nih.gov/pubmed/37959001
http://dx.doi.org/10.3390/ijms242116013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648567/
https://www.ncbi.nlm.nih.gov/pubmed/37959001
http://dx.doi.org/10.3390/ijms242116013

Ejemplares similares